Connect Biopharma Holdings Limited - American Depositary Shares — Balance Sheet (NASDAQ:CNTB) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics Dividends

Quarterly Annual

Total assets 291.05 M174.01 M125.89 M101.28 M Total liabilities 18.8 M16.52 M24.85 M9.12 M Total equity 272.26 M157.49 M101.04 M92.17 M Total liabilities & shareholders' equities 291.05 M174.01 M125.89 M101.28 M Total debt ———— Net debt ————

Haberler

Connect Biopharma Holdings Limited (CNTB) Discusses Development Strategy for Next-Generation Biologic Targeting Acute and Chronic Respiratory Diseases Transcript

Connect Biopharma hissesi, solunum ilacı potansiyeli nedeniyle BTIG’den Al tavsiyesi aldı

Connect Biopharma stock initiated with Buy rating at BTIG on respiratory drug potential

This Immuneering Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Connect Biopharma Hldgs (NASDAQ:CNTB), Immuneering (NASDAQ:IMRX)

H.C. Wainwright, Connect Biopharma hissesi için Al tavsiyesini 7 dolar hedefiyle yineledi

H.C. Wainwright reiterates Buy rating on Connect Biopharma stock at $7 target

Connect Biopharma Posts Q2 Revenue Drop

What Makes Connect Biopharma Holdings Limited Sponsored ADR (CNTB) a Strong Momentum Stock: Buy Now?

Connect Biopharma stock rating reiterated as Outperform by Northland

Connect Biopharma appoints Jim Schoeneck to board of directors

Connect Biopharma appoints James A. Schoeneck to board of directors

Connect Biopharma stock rises after announcing plan to terminate ADR program